ArticleMolecular medicine reports2020

SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.

Jun Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.